Results 61 to 70 of about 3,330,000 (287)

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

open access: yesMolecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris   +10 more
wiley   +1 more source

Political connections and the process of going public: evidence from China [PDF]

open access: yes
We examine how political connections impact the process of going public. Specifically, we test how political connections impact the pricing of newly offered shares, the magnitude of underpricing, and the fixed cost of going public.
Francis , Bill B   +2 more
core  

Datasonic: Going Public [PDF]

open access: yes, 2017
At 8.00 am on January 6, 2012, the Chief Operating Officer (COO) of Datasonic was entering his office which was located at its headquarters in Kuala Lumpur.Raymond, the COO,began looking at all the documents that were placed on his table.
Mohd Rashid, Rasidah   +1 more
core  

Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer

open access: yesMolecular Oncology, EarlyView.
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta   +10 more
wiley   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

open access: yesMolecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

open access: yesMolecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley   +5 more
wiley   +1 more source

SEMI-PUBLIC RESTRUCTURING TO UPHOLD GOOD FAITH AND GOING CONCERN IN INDONESIAN PUBLIC COMPANY BANKRUPTCY

open access: yesIndonesia Private Law Review
Indonesia’s insolvency framework is currently suboptimal in accomodating rapid creditor enforcement with preserving viable firms, particularly publicly listed companies where market signaling and minority interests are at stake. This article proposes the
Itok Dwi Kurniawan   +4 more
doaj   +1 more source

Initial Public Offerings: The Relevance of the Market Timing Hypothesis Under Conditions of the Czech Capital Market [PDF]

open access: yesJournal of Competitiveness, 2011
In this article, the authors study the relevance of the market timing hypothesis of going public, which tends to explain the lower post-issue operating performance of Czech initial public offerings.
Meluzín Tomáš, Zinecker Marek
doaj  

ANALISIS KEBIJAKAN DIVIDEN KAS DAN LIKUIDITAS SAHAM PERUSAHAAN MANUFAKTUR YANG GOING PUBLIC DI BURSA EFEK INDONESIA DITINJAU DARI DIVIDEN SIGNALING THEORY

open access: yesJurnal ASET (Akuntansi Riset), 2012
ANALISIS KEBIJAKAN DIVIDEN KAS DAN LIKUIDITAS SAHAM PERUSAHAAN MANUFAKTUR YANG GOING PUBLIC DI BURSA EFEK INDONESIA DITINJAU DARI DIVIDEN SIGNALING ...
Ferry Hendro Basuki
doaj   +1 more source

Going Public When You Can in Biotechnology [PDF]

open access: yes
Scientist-entrepreneurs prominent in biotech and other high-technology industries view going public not as a cost-effective source of capital but as a cross between selling a now-proven innovation and winning a lottery. Unlike most empirical IPO analyses
Lynne G. Zucker, Michael R. Darby
core  

Home - About - Disclaimer - Privacy